相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible hard lesions
Federico Garrido et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
Rupal Ramakrishnan et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Therapy fails, patients don't
Lee M. Ellis et al.
NATURE MEDICINE (2010)
Immunotherapy of distant metastatic disease
D. Schadendorf et al.
ANNALS OF ONCOLOGY (2009)
Complete Regression of Advanced Primary and Metastatic Mouse Melanomas following Combination Chemoimmunotherapy
Judith Kohlmeyer et al.
CANCER RESEARCH (2009)
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients
Paola Nistico et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis
Eva Jimenez-Medina et al.
BMC CANCER (2008)
Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations
Natalia Aptsiauri et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling
Hirobumi Asai et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Combination of docetaxel and recombinant vaccine enhances T-Cell responses and antitumor activity: Effects of docetaxel on immune enhancement
Charlie T. Garnett et al.
CLINICAL CANCER RESEARCH (2008)
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy
Rafael Carretero et al.
IMMUNOGENETICS (2008)
Cancer and Immune Response: Old and New Evidence for Future Challenges
Luis de la Cruz-Merino et al.
ONCOLOGIST (2008)
Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer
Koji Oba et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination
Teresa Cabrera et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
A randomized phase III trial of postoperative adjuvant therapy with S-1 alone versus S-1 plus PSK for stage II/IIIA gastric cancer: Hokuriku- Kinki immunochemo-therapy study group-gastric cancer (HKIT-GC)
Yuji Ueda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2006)
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Eric A. Reits et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials
J Sakamoto et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer
PM Arlen et al.
CLINICAL CANCER RESEARCH (2006)
Innate immune recognition of viral infection
T Kawai et al.
NATURE IMMUNOLOGY (2006)
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma
SA Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2005)
Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cells
E Jiménez et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Immune selection of hot-spot β2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy
CC Chang et al.
JOURNAL OF IMMUNOLOGY (2005)
Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study
S Ohwada et al.
BRITISH JOURNAL OF CANCER (2004)
The paradox of T cell-mediated antitumor immunity in spite of poor clinical outcome in human melanoma
A Anichini et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Escape from immunotherapy: possible mechanisms that influence tumor regression/progression
M Ahmad et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity
MM Whitmore et al.
CANCER RESEARCH (2004)
MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components
A Garcia-Lora et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Polyclonal CTL responses observed in melanoma patients vaccinated with dendritic cells pulsed with a MAGE-3.Al peptide
D Godelaine et al.
JOURNAL OF IMMUNOLOGY (2003)
HLA class I antigen abnormalities and immune escape by malignant cells
B Seliger et al.
SEMINARS IN CANCER BIOLOGY (2002)
Progress in human tumour immunology and immunotherapy
SA Rosenberg
NATURE (2001)
Generation of T cells specific for the wild-type sequence p53264-272 peptide in cancer patients:: Implications for immunoselection of epitope loss variants
TK Hoffmann et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
